410 related articles for article (PubMed ID: 33202420)
1. EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity.
Gandhi MK; Hoang T; Law SC; Brosda S; O'Rourke K; Tobin JWD; Vari F; Murigneux V; Fink L; Gunawardana J; Gould C; Oey H; Bednarska K; Delecluse S; Trappe RU; Merida de Long L; Sabdia MB; Bhagat G; Hapgood G; Blyth E; Clancy L; Wight J; Hawkes E; Rimsza LM; Maguire A; Bojarczuk K; Chapuy B; Keane C
Blood; 2021 Mar; 137(11):1468-1477. PubMed ID: 33202420
[TBL] [Abstract][Full Text] [Related]
2. Integrated genetic analyses of immunodeficiency-associated Epstein-Barr virus- (EBV) positive primary CNS lymphomas.
Kaulen LD; Denisova E; Hinz F; Hai L; Friedel D; Henegariu O; Hoffmann DC; Ito J; Kourtesakis A; Lehnert P; Doubrovinskaia S; Karschnia P; von Baumgarten L; Kessler T; Baehring JM; Brors B; Sahm F; Wick W
Acta Neuropathol; 2023 Sep; 146(3):499-514. PubMed ID: 37495858
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus as a possible etiologic agent in primary central nervous system lymphoma in immunocompetent individuals.
Tandon A; Challa S; Shanmugam M; Gopalan S; Paul RT; Digumarthi R
Neurol India; 2009; 57(1):36-40. PubMed ID: 19305074
[TBL] [Abstract][Full Text] [Related]
4. The perivascular microenvironment in Epstein-Barr virus positive primary central nervous system lymphoma: The role of programmed cell death 1 and programmed cell death ligand 1.
Sugita Y; Furuta T; Ohshima K; Komaki S; Miyoshi J; Morioka M; Abe H; Nozawa T; Fujii Y; Takahashi H; Kakita A
Neuropathology; 2018 Apr; 38(2):125-134. PubMed ID: 29067721
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus DNA load in cerebrospinal fluid and plasma of patients with AIDS-related lymphoma.
Bossolasco S; Cinque P; Ponzoni M; Vigano MG; Lazzarin A; Linde A; Falk KI
J Neurovirol; 2002 Oct; 8(5):432-8. PubMed ID: 12402169
[TBL] [Abstract][Full Text] [Related]
6. Ganciclovir is associated with low or undetectable Epstein-Barr virus DNA load in cerebrospinal fluid of patients with HIV-related primary central nervous system lymphoma.
Bossolasco S; Falk KI; Ponzoni M; Ceserani N; Crippa F; Lazzarin A; Linde A; Cinque P
Clin Infect Dis; 2006 Feb; 42(4):e21-5. PubMed ID: 16421782
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus (EBV)-associated primary central nervous system lymphoma: is incidence of EBV expression associated with median survival time?
Utsuki S; Oka H; Miyajima Y; Kijima C; Yasui Y; Fujii K
Brain Tumor Pathol; 2011 Apr; 28(2):145-9. PubMed ID: 21327439
[TBL] [Abstract][Full Text] [Related]
8. In-depth characterization of the tumor microenvironment in central nervous system lymphoma reveals implications for immune-checkpoint therapy.
Marcelis L; Antoranz A; Delsupehe AM; Biesemans P; Ferreiro JF; Debackere K; Vandenberghe P; Verhoef G; Gheysens O; Cattoretti G; Bosisio FM; Sagaert X; Dierickx D; Tousseyn T
Cancer Immunol Immunother; 2020 Sep; 69(9):1751-1766. PubMed ID: 32335702
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of cerebrospinal fluid EBV-DNA and IL-10 as markers for in vivo diagnosis of AIDS-related primary central nervous system lymphoma.
De Luca A; Antinori A; Cingolani A; Larocca LM; Linzalone A; Ammassari A; Scerrati M; Roselli R; Tamburrini E; Ortona L
Br J Haematol; 1995 Aug; 90(4):844-9. PubMed ID: 7669663
[TBL] [Abstract][Full Text] [Related]
10. The genomic and transcriptional landscape of primary central nervous system lymphoma.
Radke J; Ishaque N; Koll R; Gu Z; Schumann E; Sieverling L; Uhrig S; Hübschmann D; Toprak UH; López C; Hostench XP; Borgoni S; Juraeva D; Pritsch F; Paramasivam N; Balasubramanian GP; Schlesner M; Sahay S; Weniger M; Pehl D; Radbruch H; Osterloh A; Korfel A; Misch M; Onken J; Faust K; Vajkoczy P; Moskopp D; Wang Y; Jödicke A; Trümper L; Anagnostopoulos I; Lenze D; Küppers R; Hummel M; Schmitt CA; Wiestler OD; Wolf S; Unterberg A; Eils R; Herold-Mende C; Brors B; ; Siebert R; Wiemann S; Heppner FL
Nat Commun; 2022 May; 13(1):2558. PubMed ID: 35538064
[TBL] [Abstract][Full Text] [Related]
11. Primary central nervous system lymphomas in immunocompetent individuals: histology, Epstein-Barr virus genome, Ki-67 proliferation index, p53 and bcl-2 gene expression.
Krogh-Jensen M; Johansen P; D'Amore F
Leuk Lymphoma; 1998 Jun; 30(1-2):131-42. PubMed ID: 9669683
[TBL] [Abstract][Full Text] [Related]
12. Epstein Barr virus-associated primary CNS lymphomas in elderly patients on immunosuppressive medications.
Kleinschmidt-DeMasters BK; Damek DM; Lillehei KO; Dogan A; Giannini C
J Neuropathol Exp Neurol; 2008 Nov; 67(11):1103-11. PubMed ID: 18957891
[TBL] [Abstract][Full Text] [Related]
13. Experimental treatment of Epstein-Barr virus-associated primary central nervous system lymphoma.
Roychowdhury S; Peng R; Baiocchi RA; Bhatt D; Vourganti S; Grecula J; Gupta N; Eisenbeis CF; Nuovo GJ; Yang W; Schmalbrock P; Ferketich A; Moeschberger M; Porcu P; Barth RF; Caligiuri MA
Cancer Res; 2003 Mar; 63(5):965-71. PubMed ID: 12615710
[TBL] [Abstract][Full Text] [Related]
14. [Investigation of the clinicopathologic features, immunophenotype and Epstein-Barr virus infection of primary central nervous system lymphoma].
Xu H; Li G; Liu W; Zhang S; Li F
Zhonghua Bing Li Xue Za Zhi; 2001 Aug; 30(4):260-3. PubMed ID: 11758213
[TBL] [Abstract][Full Text] [Related]
15. B-cell posttransplant lymphoproliferative disorder isolated to the central nervous system is Epstein-Barr virus positive and lacks p53 and Myc expression by immunohistochemistry.
Sundin A; Grzywacz BJ; Yohe S; Linden MA; Courville EL
Hum Pathol; 2017 Mar; 61():140-147. PubMed ID: 27993575
[TBL] [Abstract][Full Text] [Related]
16. A clinicopathological study of primary central nervous system lymphomas & their association with Epstein-Barr virus.
Sharma MC; Gupta RK; Kaushal S; Suri V; Sarkar C; Singh M; Kale SS; Sahoo RK; Kumar L; Raina V
Indian J Med Res; 2016 May; 143(5):605-15. PubMed ID: 27488004
[TBL] [Abstract][Full Text] [Related]
17. Epstein Barr virus genotypes and LMP-1 variants in HIV-infected patients.
Correa RM; Fellner MD; Durand K; Redini L; Alonio V; Yampolsky C; Colobraro A; Sevlever G; Teyssié A; Benetucci J; Picconi MA
J Med Virol; 2007 Apr; 79(4):401-7. PubMed ID: 17311329
[TBL] [Abstract][Full Text] [Related]
18. Lessons from Epstein-Barr virus DNA detection in cerebrospinal fluid as a diagnostic tool for EBV-induced central nervous system dysfunction among HIV-positive patients.
Wang Y; Yang J; Wen Y
Biomed Pharmacother; 2022 Jan; 145():112392. PubMed ID: 34781140
[TBL] [Abstract][Full Text] [Related]
19. Role of exosomes as a proinflammatory mediator in the development of EBV-associated lymphoma.
Higuchi H; Yamakawa N; Imadome KI; Yahata T; Kotaki R; Ogata J; Kakizaki M; Fujita K; Lu J; Yokoyama K; Okuyama K; Sato A; Takamatsu M; Kurosaki N; Alba SM; Azhim A; Horie R; Watanabe T; Kitamura T; Ando K; Kashiwagi T; Matsui T; Okamoto A; Handa H; Kuroda M; Nakamura N; Kotani A
Blood; 2018 Jun; 131(23):2552-2567. PubMed ID: 29685921
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus-associated primary central nervous system lymphoma in a patient with adult T-cell leukemia / lymphoma.
Amano M; Marutsuka K; Sugimoto T; Todaka T; Setoyama M
J Dermatol; 2011 Jun; 38(6):575-80. PubMed ID: 21366675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
